1,720
Views
32
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells

, , , , , , , & show all
Pages 735-742 | Received 16 Oct 2014, Accepted 25 Oct 2014, Published online: 30 Mar 2015

Figures & data

Figure 1. FT-IR diagram of the Structure of (A) NIPAAm-MAA copolymer (B) curcumin-loaded NIPAA-MAA.

Figure 1. FT-IR diagram of the Structure of (A) NIPAAm-MAA copolymer (B) curcumin-loaded NIPAA-MAA.

Figure 2. 1H NMR spectrum of the NIPAAm-MAA co-polymer.

Figure 2. 1H NMR spectrum of the NIPAAm-MAA co-polymer.

Figure 3. Scanning electron microscopy: (A) NIPAAm-MAA co-polymer (B) Curcumin-loaded NIPAAm-MAA.

Figure 3. Scanning electron microscopy: (A) NIPAAm-MAA co-polymer (B) Curcumin-loaded NIPAAm-MAA.

Figure 4. Curcumin release from the nanoparticles at different pH levels and temperatures.

Figure 4. Curcumin release from the nanoparticles at different pH levels and temperatures.

Figure 5. (A) 24-h MTT assay results. The cytotoxic effects of different concentrations of free curcumin and curcumin-loaded NIPAAm-MAA on the MCF-7 cell line. (B) 48-h MTT assay results. (C) 72-h MTT assay results. (D) The cytotoxic effects of curcumin-loaded NIPAAm-MAA nanoparticles on the MCF-7 cell line at different times. Analysis of the MTT assay results showed a time-dependent decrease in the viability of MCF-7 for curcumin-loaded NIPAAm-MAA nanoparticles.

Figure 5. (A) 24-h MTT assay results. The cytotoxic effects of different concentrations of free curcumin and curcumin-loaded NIPAAm-MAA on the MCF-7 cell line. (B) 48-h MTT assay results. (C) 72-h MTT assay results. (D) The cytotoxic effects of curcumin-loaded NIPAAm-MAA nanoparticles on the MCF-7 cell line at different times. Analysis of the MTT assay results showed a time-dependent decrease in the viability of MCF-7 for curcumin-loaded NIPAAm-MAA nanoparticles.

Table I. IC50 values of curcumin and curcumin-loaded NIPAAm-MAA at different times of incubation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.